Marsh & McLennan Companies
Stock Forecast, Prediction & Price Target
Marsh & McLennan Companies (MMC) stock Price Target by analysts
$231.17
Potential upside: 9.33%
Marsh & McLennan Companies price prediction
What is Marsh & McLennan Companies stock analysts` prediction?
Marsh & McLennan Companies stock forecast: Based on 5 Wall Street analysts` predicted price targets for Marsh & McLennan Companies in the last 3 months, the avarage price target is $231.17, with a high forecast of $NaN. The average price target represents a 9.33% change from the last price of $211.43.
Disclaimer: This is not investment advice. Don't use price targets as the only investment indicator. Always remember to do your own thorough research and due diligence before making an investment decision.
Marsh & McLennan Companies stock Price Target by analysts
Full breakdown of analysts given Marsh & McLennan Companies price targets
| Analyst name & company | Analyst win rate | Publish date | Price target | Price when posted | Source | Historical targets |
|---|---|---|---|---|---|---|
Michael Zaremski BMO Capital | 0% 0/2 | 11 months ago | $228 7.83% upside | $222.06 | StreetInsider | Previous targets (1) |
Mark Dwelle RBC Capital | 0% 0/3 | 12 months ago | $242 14.45% upside | $226.92 | StreetInsider | Previous targets (2) |
Robert Cox Goldman Sachs | 0% 0/1 | 12 months ago | $220 4.05% upside | $226.92 | StreetInsider | Previous targets (0) |
Harry Fong Roth Capital | 0% 0/2 | 12 months ago | $230 8.78% upside | $225.88 | TheFly | Previous targets (1) |
Joshua Shanker Bank of America Securities | 0% 0/1 | 12 months ago | $250 18.24% upside | $226.76 | TheFly | Previous targets (0) |
Michael Zaremski BMO Capital | 0% 0/2 | 12 months ago | $217 2.63% upside | $224.01 | StreetInsider | Previous targets (1) |
Alex Scott Barclays | 0% 0/1 | about 1 year ago | $236 11.62% upside | $231.42 | StreetInsider | Previous targets (0) |
Harry Fong Roth Capital | 0% 0/2 | about 1 year ago | $220 4.05% upside | $217.42 | TheFly | Previous targets (1) |
Mark Dwelle RBC Capital | 0% 0/3 | over 1 year ago | $228 7.83% upside | $210.94 | StreetInsider | Previous targets (2) |
Mark Dwelle RBC Capital | 0% 0/3 | over 1 year ago | $210 -0.67% downside | $201.73 | StreetInsider | Previous targets (2) |
Elyse Greenspan Wells Fargo | 0% 0/1 | over 1 year ago | $213 0.74% upside | $201.73 | StreetInsider | Previous targets (0) |
David Motemaden Evercore ISI | 0% 0/1 | over 1 year ago | $221 4.52% upside | $201.73 | StreetInsider | Previous targets (0) |
Paul Newsome Piper Sandler | 50% 1/2 | over 1 year ago | $211 -0.20% downside | $196.29 | TheFly | Previous targets (1) |
Unknown Citigroup | N/A | over 2 years ago | $190 -10.13% downside | $175.28 | Benzinga | N/A |
Unknown Jefferies | N/A | over 2 years ago | $178 -15.81% downside | $170.96 | Benzinga | N/A |
Andrew Kligerman Credit Suisse | 100% 1/1 | almost 3 years ago | $157 -25.74% downside | $165.7 | TheFly | Previous targets (0) |
Unknown Citigroup | N/A | almost 3 years ago | $185 -12.50% downside | $168.57 | Benzinga | N/A |
Unknown Morgan Stanley | N/A | almost 3 years ago | $150 -29.05% downside | $169.58 | Benzinga | N/A |
John Heagerty Atlantic Equities | 100% 1/1 | almost 3 years ago | $185 -12.50% downside | $163.01 | TheFly | Previous targets (0) |
Unknown Raymond James | N/A | about 3 years ago | $180 -14.86% downside | $158.12 | Benzinga | N/A |
Unknown Jefferies | N/A | about 3 years ago | $181 -14.39% downside | $155.95 | Benzinga | N/A |
Unknown Morgan Stanley | N/A | over 3 years ago | $163 -22.90% downside | $149.77 | Benzinga | N/A |
Unknown Wells Fargo | N/A | over 3 years ago | $183 -13.44% downside | $157.93 | Benzinga | N/A |
Unknown Wells Fargo | N/A | over 3 years ago | $164 -22.43% downside | $175.32 | Benzinga | N/A |
Unknown Piper Sandler | N/A | over 3 years ago | $197 -6.82% downside | $175.76 | Benzinga | N/A |
Unknown Raymond James | N/A | over 3 years ago | $190 -10.13% downside | $178.7 | Benzinga | N/A |
Unknown RBC Capital | N/A | over 3 years ago | $185 -12.50% downside | $178.7 | Benzinga | N/A |
Unknown J.P. Morgan | N/A | over 3 years ago | $163 -22.90% downside | $179.6 | Benzinga | N/A |
Phil Stefano Deutsche Bank | 100% 1/1 | over 4 years ago | $135 -36.14% downside | $132.19 | TheFly | Previous targets (0) |
Paul Newsome Piper Sandler | 50% 1/2 | over 4 years ago | $145 -31.41% downside | $132.19 | TheFly | Previous targets (1) |
Marsh & McLennan Companies Financial Estimates
Marsh & McLennan Companies Revenue Estimates
Marsh & McLennan Companies EBITDA Estimates
Marsh & McLennan Companies Earnings per Share Estimates
| Passed | Analyst forecast | ||||||
|---|---|---|---|---|---|---|---|
| Metric | 12/31/2021 | 12/31/2022 | 12/31/2023 | 12/31/2025 | 12/31/2026 | 12/31/2027 | |
Revenue
% change YoY
| $19.82B N/A | $20.72B 4.54% | $22.73B 9.72% | Avg: $25.82B Low: $25.50B High: $26.27B avg. 13.58% | Avg: $27.14B Low: $26.84B High: $27.53B avg. 5.12% | Avg: $29.29B Low: $28.96B High: $29.70B avg. 7.91% | |
Net Income
% change YoY
| $3.14B N/A | $3.05B -2.95% | $3.75B 23.14% | Avg: $4.56B Low: $4.42B High: $4.89B avg. 21.51% | Avg: $4.83B Low: $4.92B High: $5.36B avg. 5.96% | Avg: $5.92B Low: $5.83B High: $6.03B avg. 22.52% | |
EBITDA
% change YoY
| $5.33B N/A | $5.24B -1.66% | $6.31B 20.34% | Avg: $6.47B Low: $6.39B High: $6.59B avg. 2.56% | Avg: $6.81B Low: $6.73B High: $6.90B avg. 5.12% | Avg: $7.35B Low: $7.26B High: $7.45B avg. 7.91% | |
EPS
% change YoY
| $6.2 N/A | $6.11 -1.45% | $7.6 24.38% | Avg: $9.4 Low: $8.87 High: $9.8 avg. 23.74% | Avg: $10.26 Low: $9.87 High: $10.76 avg. 9.09% | Avg: $11.88 Low: $11.7 High: $12.09 avg. 15.73% | |
Operating Expenses
% change YoY
| $4.08B N/A | $4.36B 7.00% | $4.74B 8.53% | Avg: $3.01B Low: $2.98B High: $3.07B avg. -36.33% | Avg: $3.17B Low: $3.13B High: $3.21B avg. 5.12% | Avg: $3.42B Low: $3.38B High: $3.47B avg. 7.91% | |
FAQ
What is Marsh & McLennan Companies stock earnings growth forecast?
Wall Street analysts estimate the annual average earnings growth rate of 16.66% in 2025-2027.
We have gathered data from 13 analysts. Their low estimate is 4.42B, average is 4.56B and high is 4.89B.
What is Marsh & McLennan Companies stock revenue growth forecast?
Wall Street analysts forecast annual average revenue growth of 8.87% in 2025-2027.
We have gathered data from 12 analysts. Their low revenue estimate is $25.50B, average is $25.82B and high is $26.27B.
What is Marsh & McLennan Companies stock earnings per share growth forecast?
Wall Street analysts forecast annual average earnings growth of 16.19% in 2025-2027.
We have gathered data from 13 analysts. Their low earnings per share estimate is $8.87, average is $9.4 and high is $9.8.
What is the best performing analyst?
In the last twelve months 5 analysts have been covering Marsh & McLennan Companies stock. The most successful analyst is Michael Zaremski.